Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2

被引:17
作者
Cao, Huibi [1 ]
Mai, Juntao [2 ]
Zhou, Zhichang [2 ]
Li, Zhijie [2 ]
Duan, Rongqi [1 ]
Watt, Jacqueline [2 ]
Chen, Ziyan [1 ,3 ]
Bandara, Ranmal Avinash [1 ,3 ]
Li, Ming [2 ]
Ahn, Sang Kyun [2 ]
Poon, Betty [4 ]
Christie-Holmes, Natasha [4 ]
Gray-Owen, Scott D. [2 ]
Banerjee, Arinjay [5 ,6 ,7 ]
Mossman, Karen [8 ]
Kozak, Rob [9 ]
Mubareka, Samira [9 ]
Rini, James M. [2 ,10 ]
Hu, Jim [1 ,3 ]
Liu, Jun [2 ]
机构
[1] Hosp Sick Children, Translat Med Program, Res Inst, Toronto, ON, Canada
[2] Univ Toronto, Fac Med, Dept Mol Genet, Toronto, ON, Canada
[3] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[4] Univ Toronto, Fac Med, Combined Containment Level Unit 3, Toronto, ON, Canada
[5] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada
[6] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK, Canada
[7] Univ Waterloo, Dept Biol, Waterloo, ON, Canada
[8] McMaster Univ, McMaster Immunol Res Ctr, Dept Med, Inst Infect Dis Res, Hamilton, ON, Canada
[9] Sunnybrook Heath Sci Ctr, Toronto, ON, Canada
[10] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
COVID-19; HD-Ad; Nasal delivery; SARS-CoV2; Vaccine; DEPENDENT ADENOVIRAL VECTORS; RECEPTOR-BINDING DOMAIN; TRANSGENE EXPRESSION; GENE-TRANSFER; IMMUNITY; DIFFERENTIATION; INFECTION; DELIVERY;
D O I
10.1186/s13578-021-00723-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background The ongoing COVID-19 pandemic has resulted in 185 million recorded cases and over 4 million deaths worldwide. Several COVID-19 vaccines have been approved for emergency use in humans and are being used in many countries. However, all the approved vaccines are administered by intramuscular injection and this may not prevent upper airway infection or viral transmission. Results Here, we describe a novel, intranasally delivered COVID-19 vaccine based on a helper-dependent adenoviral (HD-Ad) vector. The vaccine (HD-Ad_RBD) produces a soluble secreted form of the receptor binding domain (RBD) of the SARS-CoV-2 spike protein and we show it induced robust mucosal and systemic immunity. Moreover, intranasal immunization of K18-hACE2 mice with HD-Ad_RBD using a prime-boost regimen, resulted in complete protection of the upper respiratory tract against SARS-CoV-2 infection. Conclusion Our approaches provide a powerful platform for constructing highly effective vaccines targeting SARS-CoV-2 and its emerging variants.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] The pH Effects on SARS-CoV and SARS-CoV-2 Spike Proteins in the Process of Binding to hACE2
    Xie, Yixin
    Guo, Wenhan
    Lopez-Hernadez, Alan
    Teng, Shaolei
    Li, Lin
    [J]. PATHOGENS, 2022, 11 (02):
  • [22] New mouse model for inducible hACE2 expression enables to dissect SARS-CoV-2 pathology beyond the respiratory system
    Gambini, Federica
    Arbon, Dominik
    Nickl, Petr
    Zatecka, Vaclav
    Fedosieieva, Olha
    Labaj, Juraj
    Novosadova, Vendula
    Trylcova, Jana
    Weber, Jan
    Prochazka, Jan
    Balounova, Jana
    Sedlacek, Radislav
    [J]. MAMMALIAN GENOME, 2025, : 403 - 416
  • [23] Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
    Tostanoski, Lisa H.
    Wegmann, Frank
    Martinot, Amanda J.
    Loos, Carolin
    McMahan, Katherine
    Mercado, Noe B.
    Yu, Jingyou
    Chan, Chi N.
    Bondoc, Stephen
    Starke, Carly E.
    Nekorchuk, Michael
    Busman-Sahay, Kathleen
    Piedra-Mora, Cesar
    Wrijil, Linda M.
    Ducat, Sarah
    Custers, Jerome
    Atyeo, Caroline
    Fischinger, Stephanie
    Burke, John S.
    Feldman, Jared
    Hauser, Blake M.
    Caradonna, Timothy M.
    Bondzie, Esther A.
    Dagotto, Gabriel
    Gebre, Makda S.
    Jacob-Dolan, Catherine
    Lin, Zijin
    Mahrokhian, Shant H.
    Nampanya, Felix
    Nityanandam, Ramya
    Pessaint, Laurent
    Porto, Maciel
    Ali, Vaneesha
    Benetiene, Dalia
    Tevi, Komlan
    Andersen, Hanne
    Lewis, Mark G.
    Schmidt, Aaron G.
    Lauffenburger, Douglas A.
    Alter, Galit
    Estes, Jacob D.
    Schuitemaker, Hanneke
    Zahn, Roland
    Barouch, Dan H.
    [J]. NATURE MEDICINE, 2020, 26 (11) : 1694 - +
  • [24] NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
    Guebre-Xabier, Mimi
    Patel, Nita
    Tian, Jing-Hui
    Zhou, Bin
    Maciejewski, Sonia
    Lam, Kristal
    Portnoff, Alyse D.
    Massare, Michael J.
    Frieman, Matthew B.
    Piedra, Pedro A.
    Ellingsworth, Larry
    Glenn, Gregory
    Smith, Gale
    [J]. VACCINE, 2020, 38 (50) : 7892 - 7896
  • [25] Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection
    Katzman, Chaja
    Israely, Tomer
    Melamed, Sharon
    Politi, Boaz
    Sittner, Assa
    Yahalom-Ronen, Yfat
    Weiss, Shay
    Abu Rass, Reem
    Zamostiano, Rachel
    Bacharach, Eran
    Ehrlich, Marcelo
    Paran, Nir
    Nissim, Lior
    [J]. VIRUSES-BASEL, 2022, 14 (01):
  • [26] SARS-CoV-2 infection induces thymic atrophy mediated by IFN-γ in hACE2 transgenic mice
    Rizvi, Zaigham Abbas
    Sadhu, Srikanth
    Dandotiya, Jyotsna
    Sharma, Puja
    Binayke, Akshay
    Singh, Virendra
    Das, Vinayaka
    Khatri, Ritika
    Kumar, Rajesh
    Samal, Sweety
    Kalia, Manjula
    Awasthi, Amit
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 (07)
  • [27] Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
    Rathnasinghe, Raveen
    Strohmeier, Shirin
    Amanat, Fatima
    Gillespie, Virginia L.
    Krammer, Florian
    Garcia-Sastre, Adolfo
    Coughlan, Lynda
    Schotsaert, Michael
    Uccellini, Melissa B.
    [J]. EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 2433 - 2445
  • [28] Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
    Halwe, Sandro
    Kupke, Alexandra
    Vanshylla, Kanika
    Liberta, Falk
    Gruell, Henning
    Zehner, Matthias
    Rohde, Cornelius
    Kraehling, Verena
    Gellhorn Serra, Michelle
    Kreer, Christoph
    Kluever, Michael
    Sauerhering, Lucie
    Schmidt, Jorg
    Cai, Zheng
    Han, Fei
    Young, David
    Yang, Guangwei
    Widera, Marek
    Koch, Manuel
    Werner, Anke
    Kaemper, Lennart
    Becker, Nico
    Marlow, Michael S.
    Eickmann, Markus
    Ciesek, Sandra
    Schiele, Felix
    Klein, Florian
    Becker, Stephan
    [J]. VIRUSES-BASEL, 2021, 13 (08):
  • [29] Stapled peptides as potential inhibitors of SARS-CoV-2 binding to the hACE2 receptor
    Tzotzos, Susan
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2022, 28 (09)
  • [30] SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
    Fricke, Charlie
    Pfaff, Florian
    Ulrich, Lorenz
    Halwe, Nico Joel
    Schoen, Jacob
    Timm, Laura
    Hoffmann, Weda
    Rauch, Susanne
    Petsch, Benjamin
    Hoffmann, Donata
    Beer, Martin
    Corleis, Bjoern
    Dorhoi, Anca
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 (12)